Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Dec 2, 2025
- Accession no.
- 0001673232-25-000014
- Filed
- Dec 2, 2025
- Trade date
- Dec 1, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 16 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.8M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Common Stock | MOption exerciseAcquired | +14,625 | $117.76 | +$1,722,240 | 14,625 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −1,978 | $477.94 | −$945,365.32 | 12,647 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −2,935 | $478.98 | −$1,405,806.3 | 9,712 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −4,545 | $479.79 | −$2,180,645.55 | 5,167 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −2,904 | $480.80 | −$1,396,243.2 | 2,263 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −1,691 | $481.63 | −$814,436.33 | 572 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −338 | $482.69 | −$163,149.22 | 234 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −234 | $483.42 | −$113,120.28 | 0 | Indirect | |
| Dec 1, 2025 | Common Stock | MOption exerciseAcquired | +7,875 | $146.03 | +$1,149,986.25 | 7,875 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −1,065 | $477.94 | −$509,006.1 | 6,810 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −1,581 | $478.98 | −$757,267.38 | 5,229 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −2,447 | $479.79 | −$1,174,046.13 | 2,782 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −1,563 | $480.80 | −$751,490.4 | 3,867 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −911 | $481.63 | −$438,764.93 | 2,956 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −182 | $482.69 | −$87,849.58 | 2,774 | Indirect | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −126 | $483.42 | −$60,910.92 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Common Stock | MOption exerciseDisposed | −14,625 | $0.00 | $0 | 170,250 | Indirect | |
| Dec 1, 2025 | Common Stock | MOption exerciseDisposed | −7,875 | $146.03 | −$1,149,986.25 | 21,940 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.